Cargando…
Low immunogenicity of vedolizumab determined by a simple drug-tolerant assay in patients with ulcerative colitis
Vedolizumab is a humanized monoclonal antibody against the α4β7 integrin and is approved for treatment of inflammatory bowel diseases. In this study, we evaluated the immunogenicity of vedolizumab using a simple drug-tolerant assay developed in our laboratory. Serum vedolizumab trough levels and ant...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
the Society for Free Radical Research Japan
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764101/ https://www.ncbi.nlm.nih.gov/pubmed/35068684 http://dx.doi.org/10.3164/jcbn.21-98 |